{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:43:57Z","timestamp":1793241837296,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024075","name":"Region Syddanmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtha.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:21:37Z","timestamp":1741954897000},"page":"3084-3097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The thrombin generation potential increases after feminizing gender-affirming hormone treatment, decreases after masculinizing gender-affirming hormone treatment, and is determined by the hormone treatment regimen"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8523-2078","authenticated-orcid":false,"given":"Mette","family":"B\u00f8gehave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Glintborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Lehmann","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"T\u2019Sjoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Vervalcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal Maria","family":"Wiepjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"den Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Skovsager","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else-Marie","family":"Bladbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.03.006_bib1","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/aogs.14227","article-title":"Gender incongruence in Denmark, a quantitative assessment","volume":"100","author":"Hilden","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jtha.2025.03.006_bib2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/andr.13181","article-title":"Gender affirming hormonal treatment in Danish transgender persons: a nationwide register-based study","volume":"10","author":"Glintborg","year":"2022","journal-title":"Andrology"},{"key":"10.1016\/j.jtha.2025.03.006_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"key":"10.1016\/j.jtha.2025.03.006_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.03.006_bib5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.119.13080","article-title":"Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults","volume":"74","author":"Connelly","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jtha.2025.03.006_bib6","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ejendo\/lvad170","article-title":"Cardiovascular disease in transgender people: a systematic review and meta-analysis","volume":"190","author":"van Zijverden","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jtha.2025.03.006_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/EJE-22-0306","article-title":"Cardiovascular risk in Danish transgender persons: a matched historical cohort study","volume":"187","author":"Glintborg","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jtha.2025.03.006_bib8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jth.15256","article-title":"Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen","volume":"19","author":"Scheres","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.006_bib9","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","article-title":"Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people","volume":"88","author":"Toorians","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2025.03.006_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cvr\/cvp066","article-title":"Is thrombin a key player in the \u2018coagulation-atherogenesis\u2019 maze?","volume":"82","author":"Borissoff","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jtha.2025.03.006_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1160\/TH06-07-0408","article-title":"Thrombin generation, a function test of the haemostatic-thrombotic system","volume":"96","author":"Hemker","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.006_bib12","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.006_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa262","article-title":"Global coagulation assays in transgender women on oral and transdermal estradiol therapy","volume":"105","author":"Lim","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2025.03.006_bib14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.jtha.2025.03.006_bib15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1160\/TH07-07-0439","article-title":"Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography","volume":"98","author":"Tchaikovski","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.006_bib16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/gme.0b013e31820eee88","article-title":"Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens","volume":"18","author":"Scarabin","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.jtha.2025.03.006_bib17","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0455","article-title":"Testosterone therapy increases the anticoagulant potential in men with opioid-induced hypogonadism: a randomized, placebo-controlled study","volume":"12","author":"B\u00f8gehave","year":"2023","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jtha.2025.03.006_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.thromres.2019.08.011","article-title":"Testosterone treatment and association with thrombin generation and coagulation inhibition in Klinefelter syndrome: a cross-sectional study","volume":"182","author":"Chang","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.03.006_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.eurpsy.2010.04.009","article-title":"A European network for the investigation of gender incongruence: the ENIGI initiative","volume":"27","author":"Kreukels","year":"2012","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jtha.2025.03.006_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jsxm.2016.03.371","article-title":"A European network for the investigation of gender incongruence: endocrine part","volume":"13","author":"Dekker","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.jtha.2025.03.006_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"key":"10.1016\/j.jtha.2025.03.006_bib22","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/jc.2018-02138","article-title":"Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen","volume":"104","author":"van Velzen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2025.03.006_bib23","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.jtha.2025.03.006_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100118","article-title":"Combined oral contraceptives may activate the contact system in healthy women","volume":"7","author":"Strandberg","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.006_bib25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/clinem\/dgad658","article-title":"Testosterone replacement therapy in Klinefelter syndrome-follow-up study associating hemostasis and RNA expression","volume":"109","author":"Chang","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2025.03.006_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/j.1939-4640.2002.tb02272.x","article-title":"Contraceptive steroids influence the hemostatic activation state in healthy men","volume":"23","author":"Zitzmann","year":"2002","journal-title":"J Androl"},{"key":"10.1016\/j.jtha.2025.03.006_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jwh.2011.2839","article-title":"Are all estrogens created equal? A review of oral vs. transdermal therapy","volume":"21","author":"Goodman","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jtha.2025.03.006_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2147\/JBM.S379841","article-title":"Hematological profile changes among oral contraceptive users: a narrative review","volume":"13","author":"Tekle","year":"2022","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtha.2025.03.006_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0010-7824(98)00020-1","article-title":"Blood coagulation and oral contraceptives. A critical review","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2025.03.006_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102197","article-title":"Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays","volume":"7","author":"Bouck","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.006_bib31","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2017-03-745349","article-title":"Red blood cells in thrombosis","volume":"130","author":"Byrnes","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.006_bib32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1055\/s-0037-1614084","article-title":"A comparison of two sodium citrate concentrations in two evacuated blood collection systems for prothrombin time and ISI determination","volume":"84","author":"van den Besselaar","year":"2000","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T05:28:59Z","timestamp":1758950939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625001497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1538783625001497"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.03.006","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The thrombin generation potential increases after feminizing gender-affirming hormone treatment, decreases after masculinizing gender-affirming hormone treatment, and is determined by the hormone treatment regimen","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}